AI assistant
Sending…
RESMED INC — Director's Dealing 2025
Nov 13, 2025
30071_dirs_2025-11-13_0ea63e1f-ec70-47ec-a726-e536145b7999.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: RESMED INC (RMD)
CIK: 0000943819
Period of Report: 2025-11-11
Reporting Person: Farrell Michael J. (Director, Chairman and CEO)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2025-11-11 | ResMed Common Stock | F | 2231.545 | $250.10 | Disposed | 465634 | Direct |
| 2025-11-11 | ResMed Common Stock | F | 3459.325 | $250.10 | Disposed | 462175 | Direct |
| 2025-11-11 | ResMed Common Stock | F | 2205.697 | $250.10 | Disposed | 459969 | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| ResMed Common Stock | 2090 | Indirect |
Footnotes
F1: Disposition to issuer for tax withholding on vesting of Restricted Stock Units granted on 11/16/2022.
F2: Disposition to issuer for tax withholding on vesting of Restricted Stock Units granted on 11/16/2023.
F3: Disposition to issuer for tax withholding on vesting of Restricted Stock Units granted on 11/16/2024.
More from RESMED INC
Regulatory Filings
2026
May 26
Major Shareholding Notification
2026
Mar 27
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Feb 10
Regulatory Filings
2026
Feb 9
Director's Dealing
2026
Feb 6
Director's Dealing
2026
Feb 6
Director's Dealing
2026
Feb 3
Interim / Quarterly Report
2026
Jan 30
Earnings Release
2026
Jan 29